Innovating with Industry to drive transformation for patients and to support economic growth
Richard Fox (Strategic Business Engagement Partner – Life Sciences) and Professor Philip Newsome (Deputy Director of the NIHR Birmingham BRC) explain how collaborating with industry partners is important to the success of our BRC, driving innovations for our patients and also supporting economic growth for the UK and our region. Dr Stephen Elliman, Chief Scientific Officer at Orbsen Therapeutics provides an example of how the Birmingham BRC and the MW-ATTC has been instrumental in the growth of their company and delivery of their clinical trials of ORBCEL.
